Pulmonary complications are a significant cause for morbidity and mortality in osteogenesis imperfecta (OI). However, to date, there have been few studies that have systematically evaluated pulmonary function in individuals with OI. We analyzed spirometry measurements, including forced vital capacity (FVC) and forced expiratory volume in the first second (FEV 1 ), in a large cohort of individuals with OI (n = 217) enrolled in a multicenter, observational study. We show that individuals with the more severe form of the disease, OI type III, have significantly reduced FVC and FEV 1 which do not follow the expected trends of the normal population. We also show that "normalization" of FVC and FEV 1 using general population data to generate percent predicted values underestimates the pulmonary involvement in OI. Within each subtype of OI, we Allison Tam and Shan Chen contributed equally to this work.
and function of osteoblasts; and (e) genes whose functions are not completely understood to date. [1] [2] [3] [4] More than 90% of OI occurs due to qualitative or quantitative abnormalities of type I procollagen. 4, 5 Individuals with type I collagen-related OI are typically categorized by clinically severity into one of the four Sillence types: non-deforming (type I); perinatally lethal (type II); progressively deforming (type III);
and common variable (type IV). 2 Type I collagen is widely expressed in the human body and is a component of the extracellular matrix of many tissues and organs.
Unsurprisingly, individuals with OI can also manifest extraskeletal features that include pulmonary disease, muscle weakness, and cardiovascular abnormalities. [6] [7] [8] [9] [10] Pulmonary disease is a significant contributor to the mortality and morbidity in OI. In a register-based, nationwide cohort study from Denmark, Folkestad et al reported that the subhazard ratio for deaths caused by respiratory diseases was three times higher in OI as compared to the reference population. 11, 12 The burden of pulmonary disease in OI patients can be observed even during the neonatal period. Yimgang et al assessed the at-birth health outcomes of 77 neonates with OI (60 with OI type I, 4 with OI type III, and 13 with OI type IV) and reported that 22% had respiratory complications in the neonatal period. 13 These data demonstrate that pulmonary disease is a major contributor to the morbidity and mortality in OI, especially in the more severe forms. To date, only six studies have systematically assessed pulmonary function using spirometry in individuals with OI. [8] [9] [10] [14] [15] [16] 
| MATERIALS AND METHODS

| Study population
The establishment of the LCRC and subjects enrolled in the Longitudinal Study of Osteogenesis Imperfecta have been previously described. 5, 17 Participants were enrolled at one of five clinical sites: Overall of the 558 participants enrolled in the longitudinal study, spirometry data were available from 217 individuals (N = 107 for OI type I, N = 38 for OI type III, and N = 55 for OI type IV). Spirometry data were also available on small numbers of individuals with rarer forms of OI, including OI type V (n = 5), OI type VI (n = 1), and OI type VII (n = 2). The classification of type I collagen-related OI was made based on specific clinical characteristics that were outlined in the manual of operations (Supporting Information Table S1 ) and whenever available, genotypic data were also used to determine the subtype of OI.
| Data collection
The following data were collected for analyses from the enrollment visit of the study: age, gender, OI subtype, race and ethnicity, family history of OI (yes or no), height (cm), weight (kg), arm span (cm), ambulatory status (wheelchair bound or not), and presence or absence of scoliosis. These data were collected in a standardized manner across all sites according to instructions outlined in the manual of operations and were reported using online case report forms. 5 Height, defined as the vertical distance between crown of head and soles of feet, was measured using a wall-mounted stadiometer and recorded to the nearest 0.1 cm. When participants could not stand, supine length was measured from the heels to the top of the head. Arm span was measured as the distance from one furthermost fingertip to the other furthermost fingertip when the participant's arms were stretched out horizontally using a non-stretching long measuring tape to the nearest 0.1 cm. Arm span was measured in a single measure and was not a composite of multiple measurements. Arm span was also used to calculate height as previously described using the following formulae:
(a) for Caucasian males, height = arm span/1.03; (b) for AfricanAmerican men, height = arm span/1.06; and (c) for women height = arm span/1.01. [18] [19] [20] Spirometry was used to measure FVC and FEV 1 
| Statistical analysis
The Z-scores for height for children (age < 20 years) were calculated using growth data from the Centers for Disease Control and Prevention (CDC). 23 The height Z-scores for adults 20 years and older were calculated using the using the mean final adult height (SD) of 176.8 cm (6.7 cm) and 163.3 cm (6.1 cm) for males and females, respectively, from the CDC growth curves. 23 To visualize the trends in spirometry measures, the observed values for FVC and FEV 1 in L in OI types I, III and IV were plotted using scatter plots and non-parametric local regression (LOESS) smoothing curves were added for each OI 
| RESULTS
The characteristics of individuals enrolled in the longitudinal study with spirometry data available are outlined in Table 1 . As would be expected, individuals with type I collagen-related OI, the most common form of the disorder, accounted for 92% of all participants. The number of individuals with the rarer forms of OI were limited (n = 16) and thus, this population was excluded from statistical analyses.
| Observed FEV 1 and FVC in OI
Across all ages, both males and females with OI type III had lower FVC and FEV 1 than those with OI types I and IV ( Figure 1 ). The differences were most apparent between the second and fourth decades of life. FVC and FEV 1 were lower in females with OI type IV than those with OI type I, but a similar difference was not observed in males.
FVC and FEV 1 increased during the first three decades of life and gradually decreased thereafter in individuals with OI types I and IV. This is consistent with and comparable to the pattern in the general population. 24 The age-related increases were significantly blunted in OI type III. A FEV 1 of less than 1.5 L is considered as a marker of moderate airway impairment in the general adult population irrespective of the predicted value. 27, 28 Whereas no adults with OI type I and only two adults with OI type IV (9.5%) had FEV 1 of less than 1.5 L, 65% (11/17) of adults with OI type III had FEV 1 less than 1.5 L (χ2 test, P < 0.0001). As FEV 1 and FVC were both decreased proportionately, the FEV 1 /FVC ratios were similar between all three subtypes of collagen I-related OI ( Figure S1 ).
| Predicted FEV 1 and FVC in OI
It is an accepted standard practice to "normalize" the observed FEV 1 and FVC based on predictions for gender, race, age, and height of an individual. 21, 22, 25 We calculated the predicted FEV 1 and FVC values based on regression for gender, race, age, and height from the general population data and subsequently calculated a percent predicted value for FVC and FEV 1 in OI. 24 Calculation of predicted volumes allowed for comparison of FVC and FEV 1 in each OI type with the general population. As expected because of decreased height, the predicted As the accurate measurement of height in type III and IV OI can be difficult due to bowing of lower limb bones, scoliosis, and inability to stand, we also calculated the height based on arm span. [18] [19] [20] The coefficient of correlations between the measured height and arm span calculated height were 0.89, 0.54, and 0.67 for OI types I, III, and IV, respectively; which suggested that measured height more closely correlated with arm span calculated height in milder forms of OI ( Figure S4 ). The predicted FEV 1 and FVC were comparable when using either measured height or arm span calculated height in OI types I and IV, the predicted volumes changed significantly with the use of use of arm span imputed height in OI type III ( Figure S5 ). , mobility (wheel-chair bound or ambulatory), self-reported scoliosis (yes or no), history of bisphosphonate use (yes or no). As the vast majority of individuals in our cohort were white, race was omitted in the naïve model. After step-wise selection, the final models were generated and presented separately for males and females accounting for the interaction terms (Table 2 ).
In OI type I, where 97% of individuals were ambulatory and only 27% reported scoliosis, we found that age, age 2 , and height 2 , correlated significantly with the observed FEV 1 and FVC. This is similar to the regression results in the general population reported by Hankinson et al. 24 In individuals with OI type III, not wheelchair bound was associated significantly with a higher FEV 1 in both males and females, whereas presence of scoliosis showed a negative correlation with FVC. In OI type IV, a significant association between bisphosphonate use and FEV 1 was observed.
| DISCUSSION
To date, only six studies have systematically assessed pulmonary functions in OI. [8] [9] [10] [14] [15] [16] In most of these studies, spirometry has been used as a primary measure of pulmonary function (Table 3 ). In one of these studies, LoMauro et al 15 performed a comprehensive analysis of lung functions in OI using standard spirometry, nocturnal oxygen saturation, radiographs, opto-electronic plethysmography, and kinematic analysis and showed that in addition to abnormal spirometry volumes, individuals with OI type III had paradoxical inspiratory inward motion of the pulmonary rib cage and thoracoabdominal asynchronies. A key question to be answered is whether these diminished volumes are "appropriate-for-size" in OI or whether they portend poor cardiopulmonary outcomes. In the NHANES I cohort, 4300 men and women (age: 25-74 years) were followed for an average of 13 years; a 1-L decrement in FEV 1 in the cohort, was associated with a 60% increase in mortality even when accounting for sex, race, age, serum cholesterol, systolic blood pressure, smoking status, alcohol consumption, and body mass index. 29, 30 Similarly, in the Normative Aging height, gender, and ethnicity generated from the general population.
We show that while this normalization process is appropriate for indi- On the research front, we believe that this study is an important first step in developing OI-specific standards to predict FVC and FEV 1 and in developing pulmonary endpoints for clinical research. Whereas FVC and FEV 1 measurement remain the mainstays of evaluation of pulmonary physiology, more sophisticated measures may provide additional information. In assessing the contribution of abnormal chest wall architecture vs intrinsic lung abnormalities, the most direct, but somewhat invasive, method would be to measure intrapleural pressure using an esophageal balloon. Kyphoscoliosis, rib and vertebral fractures would lead to the generation of low negative intrapleural pressures during inhalation while restrictive lung disease due to connective tissue abnormalities would lead to the generation of very high negative intrapleural. Plethysmographic lung volumes, assessment of air flow and peak inspiratory and expiratory pressures, and the measurement of diffusing capacity and gas transfer will add to our understanding of the characteristics of the pulmonary physiology and risks in OI. Impulse oscillometry, a non-invasive, rapid, safe and validated technique that measures respiratory impedance is another modality that requires further study in OI.
In conclusion, we show that the normalization process used in spirometry analyses can underestimate the pulmonary involvement in severe forms of OI. We suggest that clinicians be aware of the limita- 
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